Emerging Infectious Diseases
Rutgers University gained emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) this week for a new test utilizing saliva to detect SARS-CoV-2, the virus that causes COVID-19.
The test comes from Rutgers’ RUCDR Infinite Biologics, the world's largest... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will pump approximately $180,000 into a new partnership with DiaSorin, Inc. to create a clinical lab test capable of identifying people infected with and recovered from the SARS-CoV-2 virus.
SARS-CoV-2 is the virus that causes... Read More »
The United Nations Foundation is awarding $10 million to CEPI, the Coalition for Epidemic Preparedness, to develop a COVID-19 vaccine.
This award is through the UN Foundation’s COVID-19 Solidarity Response Fund for the World Health Organization (WHO). The fund was set up to raise funds for... Read More »
Esri, a company that makes geographic information system (GIS) software, is working with the Federal Emergency Management Agency (FEMA) to help fight against the COVID-19 coronavirus.
Specifically, Esri will provide its mapping and analytics technology in support of a multi-agency geospatial... Read More »
Sanofi will donate 100 million doses of hydroxychloroquine to 50 countries around the world.
The French pharmaceutical company has received an increasing number of requests from local governments around the world for this product. Sanofi’s priority is to ensure supply continuity for patients... Read More »
A group of Democratic U.S. Senators will introduce a bill to establish a commission to examine the country’s response to the coronavirus pandemic.
The commission would be charged with reviewing the government’s coronavirus response and make recommendations on how it can be improved. The bill... Read More »
Boeing recently executed the initial delivery of reusable 3D-printed face shields as a means of supporting healthcare professionals working to halt COVID-19.
“Boeing is proud to stand alongside many other great American companies in the fight against COVID-19, and we are dedicated to... Read More »
One of the major problems facing governments and healthcare professionals alike in dealing with the COVID-19 pandemic has been the undetected, asymptomatic cases throughout the world, but the National Institutes of Health (NIH) now aims to track the previously unnoticed.
A study to be conducted... Read More »
In a second emergency use authorization (EUA), the United States Food and Drug Administration (FDA) has approved the decontamination of N95 and equivalent respirators for reuse by health care workers in hospitals working to contain COVID-19.
Such masks have been in short supply as hospitals... Read More »
A group of Congressional lawmakers are calling on leaders of the World Health Organization, the United Nations, and the World Organization for Animal Health to ban live wildlife markets and international trade of live wildlife.
Live wildlife markets, also known as “wet” markets, create a... Read More »
The Centers for Disease Control and Prevention (CDC) has extended the No Sail Order for all cruise ships to combat domestic spread of COVID-19.
“We are working with the cruise line industry to address the health and safety of crew at sea as well as communities surrounding U.S. cruise ship... Read More »
The malaria and arthritis drug much-touted by President Donald Trump, hydroxychloroquine, is getting its chance under the microscope now, with the beginning of a clinical trial by the National Institutes of Health to determine its potential as a COVID-19 therapy.
Testers hope the drug could have... Read More »
Every day during the COVID-19 pandemic seems to bring word of a new potential vaccine, treatment or diagnostic being considered or pursued, but the vaccine R&D team at the Coalition for Epidemic Preparedness Innovations (CEPI) has made them easier to track.
In a new analysis published in Nature... Read More »
U.S. Sen. Tammy Baldwin (D-WI) introduced legislation designed to protect first responders and frontline workers in the fight against the COVID-19 coronavirus pandemic.
The COVID–19 Workers First Protection Act (S. 3584) directs the Department of Labor (DOL) to issue an emergency temporary... Read More »
The U.S. Department of Health and Human Services (HHS) awarded roughly $1.3 billion to health centers to help them respond to the coronavirus pandemic.
The funding – through the Health Resources and Services Administration (HRSA) – went to 1,387 different health centers. The awards may be... Read More »
Teaming up with the United States government, health technology provider Royal Philips has agreed to double the production of hospital ventilators at its U.S. manufacturing sites by May and push for a four-fold increase by the third quarter.
These supplies would then be usable in both the U.S.... Read More »
Department of Health and Human Services (HHS) officials reached an agreement with DuPont to obtain Tyvek suits for frontline healthcare workers responding to the COVID-19 pandemic.
DuPont will deliver 450,000 Tyvek suits, via FedEx, to the Strategic National Stockpile (SNS) from its Hanoi,... Read More »
Nanomix is working to create a 15 minute rapid mobile COVID-19 test, capable of diagnosing current or past infection by SARS-CoV-2 through nasal and throat swabs.
The Biomedical Advanced Research and Development Authority (BARDA) is teaming up with Nanomix to achieve this, pumping $569,647 into... Read More »
A group of Democratic U.S. Senators recently urged Trump administration officials to immediately distribute an initial round of emergency funding to hospitals and other health care providers.
This funding would come from the $100 billion that was authorized to hospitals and healthcare... Read More »
The U.S. Food and Drug Administration accepted Inovio Pharmaceuticals investigational new drug (IND) application for its vaccine candidate designed to prevent COVID-19 infection.
This action by the FDA paves the way for Phase 1 clinical testing of this vaccine candidate, INO-4800, in healthy... Read More »
University of Pittsburgh School of Medicine researchers maintain when tested in mice a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic, produces antibodies for potential neutralization.
The study findings detailed via eBioMedicine, which is published by... Read More »
Actemra, a drug more commonly used to treat moderate to severe rheumatoid arthritis, will undergo a Phase 3 clinical trial for its potential to help patients suffering from COVID-19, under an expanded partnership between Roche’s Genentech and the Biomedical Advanced Research and Development... Read More »
Global healthcare company Grifols is collaborating with the Biomedical Advanced Research and Development Authority (BARDA) and the United States Department of Defense (DoD) to collect plasma and create a COVID-19 treatment based on it.
The effort is based on previous government calls for... Read More »
The federal Biomedical Advanced Research and Development Authority (BARDA) is working with OraSure Technology to develop a test for the coronavirus (COVID-19) that could bring testing closer to the patient.
OraSure’s point-of-care test will be available at home and in clinical settings. It... Read More »
GlaxoSmithKline (GSK) and Vir Biotechnology will collaborate to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.
The partnership will leverage Vir’s proprietary monoclonal antibody platform technology to identify new anti-viral antibodies... Read More »
Department of Health and Human Services (HHS) officials said the Centers for Disease Control and Prevention (CDC) would provide $186 million to state and local jurisdictions for COVID-19 support.
“Testing and surveillance is a vital piece of our efforts to beat the coronavirus, and this new... Read More »
A group of legislators recently introduced legislation designed to create a commission to assess the nation's response and make recommendations for future pandemic preparedness.
Rep. Rodney Davis (R-IL) joined 12 colleagues in presenting the Pandemic Rapid Response Act, which establishes the... Read More »
Hydroxychloroquine is flooding the Strategic National Stockpile this week as a potential treatment for COVID-19, thanks to a 30 million dose donation from Sandoz and another 1 million gifted by Bayer Pharmaceuticals.
Both hydroxychloroquine sulfate and chloroquine phosphate were given U.S. Food... Read More »
The U.S. Department of Health and Human Services (HHS) intends to purchase the ID NOW COVID-19 rapid point-of-care test developed by Abbott Diagnostics Scarborough Inc., to expand the supply of diagnostics available to state, territorial and tribal public health labs.
Designed for the ID NOW... Read More »
Massachusetts Gov. Charlie Baker announced the creation of the COVID-19 Community Tracing Collaborative (CTC) to mitigate the spread of the coronavirus in Massachusetts.
This collaboration with Partners In Health focuses on tracing the contacts of confirmed positive COVID-19 patients and... Read More »
A Republican group of legislators announced plans to introduce the Li Wenliang Global Public Health Accountability Act designed to address foreign officials who attempted to conceal early onset COVID-19 public health information.
The Act would also sanction any foreign official who may conceal a... Read More »
Puerto Rico Resident Commissioner Jenniffer González-Colón recently led a bipartisan group of lawmakers in introducing a measure that bolsters the U.S. supply chain amid the COVID-19 pandemic.
González-Colón and Reps. Donna Shalala (D-FL), Rob Bishop (R-UT), Darren Soto (D-FL), Ruben... Read More »
As part of ongoing Centers for Disease Control and Prevention (CDC) efforts to promote reliable COVID-19 information, it has modified its existing surveillance systems to form a weekly new report known as COVIDView, which will summarize and interpret data each Friday.
The first COVIDView... Read More »
The U.S. Food and Drug Administration (FDA) has stepped in to fast-track development of and access to two more investigational therapies for COVID-19 based on convalescent plasma and hyperimmune globulin from human blood.
By using blood donated from those who have recovered from the SARS-CoV-2... Read More »
Mounting a rapid and effective response to emerging public health threats is a continuing challenge, which will only become more important in an increasingly connected world, says Dr. Richard Welch, vice president and head of development services at Emergent BioSolutions Inc., a global life... Read More »
